Quantcast

Latest glioblastoma multiforme Stories

2014-11-10 08:33:36

Exploratory Study is First to Evaluate Novel microRNA Replacement Therapy for the Treatment of Malignant Pleural Mesothelioma SYDNEY, Nov.

2014-11-10 08:32:56

VANCOUVER, British Columbia and MENLO PARK, Calif., Nov.

2014-11-10 08:31:32

LOS ANGELES, Nov. 10, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced financial results for the quarter ended September 30, 2014.

2014-11-04 08:33:26

LOS ANGELES, Nov.

2014-10-30 08:35:51

Trial will test the potential synergy between a taxane and TTFields in the treatment of recurrent ovarian cancer ST. HELIER, Jersey, Oct.

2014-10-29 08:32:56

The supplement is intended to provide an overview of available knowledge regarding the use of NovoTTF Therapy for the treatment of recurrent glioblastoma, as well as its development for the treatment

2014-10-20 23:02:05

In-demand research report “Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM”

2014-10-17 23:08:13

NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has received a $1Million grant from the National Cancer Institute (NCI) “Nanoparticle-based Sensitizer for Radiation Therapy of


Word of the Day
postliminy
  • In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
  • In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.
The word 'postliminy' comes from a Latin word meaning 'threshold'.